BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AG 

Brunner Strasse 69, Obj.3

Vienna    1230  Austria
Phone: 43-1-902-50 Fax: 43-1-902-50-901


SEARCH JOBS


Industry
Biotechnology






 Company News
DVC Deutsche Venture Capital Achieves Further Successful Transactions And Exits Within Its Life Sciences Portfolio In The 1st Quarter 2005 10/19/2005 5:13:15 PM    More...
Aphton Corporation (APHT) Announces Closing Of Igeneon Acquisition 10/19/2005 5:13:07 PM    More...
Aphton Corporation (APHT) Shareholders Approve Acquisition Of Igeneon 10/19/2005 5:13:05 PM    More...
Aphton Corporation (APHT) To Acquire Igeneon Extending Its Leadership Position In Cancer Immunotherapy; Acquisition Represents Pivotal Step To Establishing A Broad Oncology Franchise 10/19/2005 5:12:28 PM    More...
Aphton Corporation (APHT) And VaxGen, Inc.'s (VXGN) Joint Venture Celltrion, Inc. Announce Commercialization And Manufacturing Agreements For IGN311 With Igeneon 10/19/2005 5:12:08 PM    More...
Igeneon Initiates Further Pivotal Phase III Clinical Trials With IGN101 Cancer Vaccine 10/19/2005 5:10:31 PM    More...
Oncology-Focused Igeneon Raises EUR26.7M, Ponders IPO 10/19/2005 5:10:16 PM    More...
Igeneon Raises EUR 26.7 Million (US$34.3 million) In A Series C Financing Round Co-Led By Burrill & Company And 3i 10/19/2005 5:10:11 PM    More...
Aphton Corporation (APHT) Reports Activity Of IGN101 In Reducing Disseminating Tumor Cells From Patients With Epithelial Cancers 10/19/2005 5:10:07 PM    More...
Igeneon Expands Management Board In 2004 10/19/2005 5:09:38 PM    More...

//-->